Chronic News and Research

RSS

Early weaning linked to chronic diseases later in life: Study

Lack of breastfeeding in infancy may lead to chronic diseases later in life say researchers. At present 90% of people aged between 35 and 40 were not breastfed as babies.

27 Jul 2010

WWHI participates in joint meeting to explore barriers to wireless communications, health care solutions

The West Wireless Health Institute today announced its participation in the first joint meeting hosted by the Federal Communications Commission and Food & Drug Administration to explore the potential barriers that may slow the convergence of wireless communications and health care solutions.

27 Jul 2010

Millennium Laboratories urges for increase in physician reimbursement for POC urine drug screening

Millennium Laboratories, Inc., a national, research-based medication monitoring company specifically focused on clinicians who treat chronic pain, strongly advocated for an increase in physician reimbursement for point-of-care urine drug screening at the Annual Clinical Laboratory Public Meeting of the Centers for Medicare and Medicaid Services on July 22, 2010.

27 Jul 2010

Age-in Study 2010 shows how age 65 has become irrelevant to boomers' retirement plans

Leading boomers (aged 63-64) want to continue working, but three times as many are unemployed today as were two years ago. They face high unemployment, unwanted early retirement, and early draws on Social Security, meaning less retirement income. This critical finding is from Deft Research's just-released Age-in Study 2010.

27 Jul 2010

Kinetic Concepts second-quarter global revenue increases 1% to $497.8 million

Kinetic Concepts, Inc. today reported second quarter 2010 total revenue of $497.8 million, an increase of 1% from the second quarter of 2009 and up 2% from the first quarter of 2010. Total revenue for the first half of 2010 was $983.6 million, a 2% increase from the prior-year period. Unfavorable foreign currency exchange movements reduced total revenue for the second quarter of 2010 by less than 1%, while favorably impacting total revenue for the first six months of 2010 by 1% compared to the corresponding periods of the prior year.

27 Jul 2010

SeeChange Health Insurance to offer value-based HSA products to California employers

SeeChange Health Insurance Company, a provider of value-based health insurance plans to employers, will offer a variety of Health Savings Account products in parts of California beginning August 1, 2010. The product launch will make SeeChange Health the first insurance company to offer value-based HSA products to California employers.

27 Jul 2010

Researchers reveal biological rationale for why corticosteroids help people with lupus

Researchers at UT Southwestern Medical Center have uncovered the biological rationale for why large doses of corticosteroids given repeatedly over several weeks may help individuals with lupus, a chronic inflammatory disease that affects more than 1 million people in the U.S.

27 Jul 2010

'Quit Smoking' Habit Changer program more effective than other popular methods

Today findings from a recent Anderson Analytics market research study were released that examined the underlying reasons for success of common methods used to stop smoking versus a new online approach. This study compared participants that completed the 42-day "Quit Smoking" program by Habit Changer against participants who used nicotine-replacement therapies or other alternatives to quit or reduce intake of cigarettes. According to the Centers for Disease Control and Prevention (CDCP), roughly 9.2 million smokers attempt to quit annually.

27 Jul 2010

Study tests new performance intervention to improve heart failure patients in outpatient setting

A study led by UCLA tested a new performance intervention to help improve adherence to national guideline-recommended therapies for heart failure patients in an outpatient setting.

27 Jul 2010

Life-saving interventions can save 11 million African women, children over next five years: Countdown report

In the next five years, 11 million African women and children could be saved by creating near-universal availability of key life-saving interventions, according to The Partnership for Maternal, Newborn & Child Health and the Countdown to 2015 Decade Report (2000-2010).

27 Jul 2010

Cash-strapped local governments threaten to hold back payments to N.Y.; Oakland council approves 4 marijuana factories

The Wall Street Journal: "Frustrated by Albany's backlog of unpaid bills, cash-strapped local governments around New York are threatening to suspend their Medicaid payments to the state. Last week, an upstate county announced that it was freezing Medicaid payments to Albany. The move, which was closely watched by other county leaders, may be the start of a broader revolt, as the consequences of the state's chronic cash shortage trickle down to the local level.

27 Jul 2010

ProtAffin signs manufacturing contract with CMC Biologics for COPD drug PA401

ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today announced it has signed a manufacturing contract with CMC Biologics' Danish operations, located in Copenhagen, Denmark for manufacture of its lead product PA401 for the treatment of chronic obstructive pulmonary disease (COPD). The contract will cover manufacture and supply of PA401 for preclinical development and early clinical development in COPD and related respiratory indications.

27 Jul 2010

Four research teams to study role of exercise in preventing, treating chronic diseases

Canadians will benefit from new insights into the link between physical activity and health as the Honourable Leona Aglukkaq, Minister of Health, today announced funding for four research teams through the Canadian Institutes of Health Research. These teams will study the effects of exercise on the body and its role in the prevention and treatment of chronic diseases including arthritis, breast cancer and heart disease.

27 Jul 2010

Australian medical devices market to grow at 9% CAGR in 2009-2012

The consequences as a result of the major Australian healthcare reform plan will impact the outlook of the medical devices industry, and possibly precipitate a series of rapid changes for the market.

27 Jul 2010

AU leaders summit kicks off, focus on maternal and child health

Heads of state from the African Union (AU) started a three-day meeting in Kampala, Uganda, on Sunday as part of the 15th AU Summit, People's Daily Online reports. Leaders will focus on maternal and child health and will discuss several other issues, including agricultural development, food security, infrastructure development and economic integration (7/26).

27 Jul 2010

NIH awards BU $1.6M grant to target protein-protein interactions with synthetic organic drugs

An interdisciplinary team of Boston University professors is launching a project to develop new ways to target protein-protein interactions with synthetic organic drugs. Financed by a four-year $1.6 million grant from the National Institutes of Health, the goal is to develop new approaches for discovering "drug-like" small molecule inhibitors against challenging protein-protein interaction (PPI) interfaces.

27 Jul 2010

New drug for type 2 diabetes, Effect of insulin on bones

In a groundbreaking finding, a new medicine Galvus (vildagliptin) has been created for people with type 2 diabetes that would lower blood glucose levels without the side effects of other medications.

26 Jul 2010

Can-Fite's CF102 decreases HCV viral load in liver cancer patients

Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange reported today that a significant decrease in HCV viral load was detected in 3 patients with liver cancer who are treated daily orally with CF102. The company is studying CF102 as a treatment for liver cancer (hepatocellular carcinoma, or HCC). The results announced today relate to data which came out of a Phase 1/2 clinical trial of CF102 in the treatment of patients with advanced HCC.

26 Jul 2010

Hospira commences EPO Phase I U.S. clinical trial in renal dysfunction patients with anemia

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with renal (kidney) dysfunction who have anemia, an important step on the road toward introducing a biosimilar product in the United States. Erythropoietin is a treatment for anemia associated with chronic renal failure and chemotherapy.

26 Jul 2010

Obesity linked to early puberty in girls

A review of more than 100 studies found overweight girls tend to reach puberty earlier than their peers do.

26 Jul 2010

Chronic News and Research

Early weaning linked to chronic diseases later in life: Study

WWHI participates in joint meeting to explore barriers to wireless communications, health care solutions

Millennium Laboratories urges for increase in physician reimbursement for POC urine drug screening

Age-in Study 2010 shows how age 65 has become irrelevant to boomers' retirement plans

Kinetic Concepts second-quarter global revenue increases 1% to $497.8 million

SeeChange Health Insurance to offer value-based HSA products to California employers

Researchers reveal biological rationale for why corticosteroids help people with lupus

'Quit Smoking' Habit Changer program more effective than other popular methods

Study tests new performance intervention to improve heart failure patients in outpatient setting

Life-saving interventions can save 11 million African women, children over next five years: Countdown report

Cash-strapped local governments threaten to hold back payments to N.Y.; Oakland council approves 4 marijuana factories

ProtAffin signs manufacturing contract with CMC Biologics for COPD drug PA401

Four research teams to study role of exercise in preventing, treating chronic diseases

Australian medical devices market to grow at 9% CAGR in 2009-2012

AU leaders summit kicks off, focus on maternal and child health

NIH awards BU $1.6M grant to target protein-protein interactions with synthetic organic drugs

New drug for type 2 diabetes, Effect of insulin on bones

Can-Fite's CF102 decreases HCV viral load in liver cancer patients

Hospira commences EPO Phase I U.S. clinical trial in renal dysfunction patients with anemia

Obesity linked to early puberty in girls

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News